| |
| |
|
| Insider
Information: |
Ketchum Steven B |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
742,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$669,274 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
742,979 |
|
|
| Total
Value |
$669,274 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2015-07-24 |
84,259 |
2010-06-30 |
0 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
|
2024-01-31 |
658,720 |
2015-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2010-06-30 |
4 |
B |
$0.28 |
$65,517 |
D/D |
238,243 |
240,595 |
2.74 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
99,940 |
340,535 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2010-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
38,969 |
379,504 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2010-07-30 |
4 |
D |
$0.49 |
$6,932 |
D/D |
(14,293) |
365,211 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,053 |
72,921 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Sr. Vice President, R & D |
• – – |
2011-02-28 |
4 |
D |
$2.10 |
$9,284 |
D/D |
(4,421) |
68,500 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-07 |
4 |
OE |
$2.09 |
$40,862 |
D/D |
19,551 |
93,512 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-07 |
4 |
S |
$5.03 |
$98,295 |
D/D |
(19,551) |
73,961 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-08 |
4 |
S |
$5.08 |
$53,364 |
D/D |
(10,503) |
73,961 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2013-11-08 |
4 |
OE |
$2.09 |
$21,951 |
D/D |
10,503 |
84,464 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
President of R&D, SVP |
• – – |
2015-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
56,500 |
56,500 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
OE |
$1.32 |
$21,986 |
D/D |
16,656 |
86,378 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2015-07-24 |
4 |
S |
$3.46 |
$21,989 |
D/D |
(6,358) |
84,259 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2016-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
117,438 |
173,938 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2016-01-31 |
4 |
D |
$1.36 |
$57,842 |
D/D |
(42,531) |
131,407 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2017-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
144,105 |
275,512 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2017-01-31 |
4 |
D |
$2.97 |
$208,601 |
D/D |
(70,236) |
205,276 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2017-10-05 |
4 |
AS |
$3.48 |
$221,199 |
D/D |
(63,479) |
141,797 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-02 |
4 |
OE |
$1.02 |
$153,583 |
D/D |
128,257 |
270,054 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-02 |
4 |
AS |
$4.25 |
$545,092 |
D/D |
(128,257) |
141,797 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-05 |
4 |
OE |
$2.04 |
$131,953 |
D/D |
64,683 |
206,480 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-05 |
4 |
AS |
$4.40 |
$284,631 |
D/D |
(64,683) |
141,797 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-11 |
4 |
OE |
$2.04 |
$5,328 |
D/D |
2,612 |
144,409 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-11 |
4 |
AS |
$4.40 |
$11,493 |
D/D |
(2,612) |
141,797 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Chief Scientific Officer |
• – – |
2018-01-23 |
4 |
OE |
$2.04 |
$275,818 |
D/D |
135,205 |
277,002 |
0 |
- |
|
132 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
